Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
• CTI Clinical Trial and Consulting Services (Cincinnati, OH) announced the following new hires: Tricia Robinson, Senior Clinical Data Associate; David Vessy, Siebel Clinical Administrator; Grace Baker, Senior Regulatory Specialist; Jordan Jemison, Research Associate; Dana Acklin, Senior Study Coordinator; Ralph Campaneria, MD, Medical Director; John Green, Senior Systems Administrator; Thomas Winrod, RN, Associate Director, Clinical Trials; Paula Ulsh, RN, BSN, Assistant Director, Medical and Scientific Affairs; and Edward A. Kouche III, CPA, as Director, International Accounting and Finance. The following promotions were also announced: Nick Schatzman to Senior Business Development Associate; Kevin Wesley to Clinical Data Associate II; Cyndi Springer to Associate Director, Clinical Operations Study Management; and Mike Bahm to Senior Director, Global IT.
• Aptiv Solutions (Reston, VA) announced the appointment of Patricia Monteforte to the role of President of Trio Clinical Resourcing, an Aptiv Solutions subsidiary devoted to clinical and regulatory staffing. Aptiv also announced their Senior Vice President of Software Development and Consulting, Vlad Dragalin, PhD, was elected as a Fellow of the American Statistical Association, the world's largest community of statisticians.
• PSI CRO (Zug, Switzerland) announced their expansion to India, and the appointment of Radhika Bobba, MD, as Regional Director for India and the Asia-Pacific region.
• ACM Global Central Lab (Rochester, NY) announced the addition of Alexander van Amerongen, MD, as Director of Anatomic Pathology.
• Packaging Coordinators Inc. (PCI) (Philadelphia, PA) announced that Peter Belden has assumed the role of General Manager for its Rockford, IL based facilities. PCI operates nine facilities in Rockford, totaling over one million square feet and employing over 1,300 associates.
Peter Belden
• Novella Clinical (Research Triangle Park, NC) announced three senior executives have assumed new leadership roles within the organization. Deborah Turunjian has been named Vice President, Oncology Clinical Development; Jamie Gault has been promoted to Global Head of Regulatory Affairs; and Kathleen Zajd has been named Vice President, Global Quality and Compliance.
• Exco InTouch (Nottingham, UK) has appointed Steve Powell as a non-executive director. Powell is the founder and Chairman of MyMeds&Me Ltd., a company focused on the capture and processing of adverse events and product complains, and Chairman of CISIV Ltd, an organization specializing in the capture and processing of real world life sciences data.
• Catalent Pharma Solutions (Somerset, NJ) named David Heyens in the new role of President of Catalent Asia Pacific.
• inVentiv Health (Burlington, MA) announced the creation of two new positions to lead its growing business in Europe and Asia. Dan Feldman will take on the new position of President of inVentiv Health Europe. Stephen J. Walter will join the company as Executive Vice President for Asia.
Dan Feldman
• Theorem Clinical Research (King of Prussia, PA) promoted UK researcher Phil Lake to head its biopharmaceutical franchise in respiratory. As Executive Director of Biopharmaceutical Development, Respiratory, Lake will be responsible for senior oversight on major projects as well as building Theorem's respiratory business globally. Theorem also announced Joseph Sgherza has been named Vice President of Biopharmaceutical Development for the Infectious Disease franchise.
Joseph Sgherza
• Association of Clinical Research Professionals (ACRP) (Alexandria, VA) announced the hiring of Teresa-Lynn (Terri) Hinkley, RN, BScN, MBA, CCRC, to serve in a new position as Deputy Executive Director for the association.
• ERT (Philadelphia, PA) announced an additional expansion of its executive management team. It has appointed Steven Herne as Executive Vice President and Chief Commercial Officer.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced it has appointed Gregory Dennis, MD, as Vice President of Global Product Development.
Gregory Dennis
• Cato Research (CATO) (Durham, NC ) announced the hire of Benjamin Alt and Kris Dyszynski. They are welcomed aboard CATO's international commercial team.
• Frontage Laboratories (Exton, PA) announced two senior-level appointments to lead its consulting service expansion in regulatory affairs and drug development strategies. Vijay Tammara, PhD, was named Vice President of Regulatory Affairs. John (Zhenze) Hu, PhD, was named Vice President, Pharmaceutical Development Consulting Services.
• TKL Research (Rochelle Park, NJ) announced that Roxanne Tavakkol has been appointed to the position of Vice President, Regulatory and Scientific Services.
• Bio-Optronics (Rochester, NY) announced that it has joined forces with the Society of Clinical Research Sites as a Global Impact Partner. The Global Impact Partners are a group of research professionals and industry providers who will work together to address the most pressing issues facing sites today, in addition to any future problems and trends.
• Forte Research Systems, Inc. (Madison, WI) announced a two-year partnership with the Society for Clinical Research Sites, a trade organization that represents global clinical research sites.
• Clinverse, Inc., (Raleigh, NC) a global technology and eclinical commerce network for clinical trials announced that it has formed a strategic partnership with OmniComm Systems, Inc., a provider of EDC solutions.
• Intralinks Holdings, Inc. (New York, NY) and IRB Services announced that the IRB Services team has selected Intralinks VIA to support all of its secure beyond-the-firewall collaboration needs.
• Theorem Clinical Research (King of Prussia, PA) announced the formation of a strategic alliance with Charles River Laboratories that will provide clients with an integrated solution from nonclinical testing and analysis through clinical development and registration.
• MedNet Solutions, (Minnetonka, MN) a global life sciences technology company specializing in clinical study management systems, announced that Accelovance, a, full-service clinical research organization focused in early phase oncology, vaccines, and general medicine development, has joined the iMedNet Partner Program.
• InVentiv Health (San Francisco, CA) announced that partner company Mytrus, Inc. won Frost & Sullivan's North American Product Leadership Award for pioneering electronic informed consent for clinical trials. Frost & Sullivan, a respected global research organization that tracks more than 250,000 companies, compared Mytrus to key competitors in a rigorous review and named Mytrus winner of the North American Product Leadership Award in Clinical Trials.
• CTI Clinical Trial and Consulting Services (Cincinnati, OH) was awarded the 2013 Goering Center Private Business Award. The Goering Center recognized finalists and category winners for their success in family and private business. An independent panel of judges, comprised of local business leaders, reviewed 550 nominees for the award, narrowed them down to 92 finalists, and then named winners in six categories (three family business and three private business), based on a company's years in business. CTI was the winner for private companies in business 15 years or less.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced the American Society for Training & Development (ASTD) has named PPD a 2013 ASTD BEST Award winner for excellence in employee learning and development. PPD was honored for implementing innovative employee training programs, which drive efficiencies in the conduct of biopharmaceutical clients' drug development programs.
• Virtify, Inc. (Lexington, MA) announced Indiana University has signed an enterprise-level contract for its Clinical Trial Registration and Results (CTRR) disclosure software. Indiana University will utilize Virtify's CTRR to fulfill their regulatory obligations by disclosing their clinical trial information to the National Institute of Health's clinicaltrials.gov.
• Greenphire (King of Prussia, PA) announced it has been ranked in the 2013 Inc. 500 list of the fastest-growing private companies in the United States. The company was ranked 192, and 21 in the software industry.
• Rho (Chapel Hill, NC) announced that the Triangle Business Journal has named the company a winner of Best Places to Work in the Triangle. The award is part of the publication's annual Best Places to Work Awards program and recognizes Rho's achievements in creating a positive work environment. Rho was the only local CRO to be honored by the news publication. Rho also announced that Carolina Parent named it one of North Carolina's Family-Friendly 50 Companies.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced it has been named to the annual InformationWeek 500 ranking of the most innovative business technology users in the United States for the fourth consecutive year.
• INC Research (Raleigh, NC) announced it is the first global CRO to implement the Clinical Research Monitor Accreditation program, an internationally recognized standard for competence in clinical research monitoring offered through the International Academy of Clinical Research.
• Cato Research (CATO) (Durham, NC) celebrated 25 years of dedicated service to the life science industry. Headquartered in the Research Triangle Park of North Carolina, CATO is a global, competitive contract research organization that includes an investment arm, Cato BioVentures.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Obe-Cel Achieves High Response Rates, Durable Outcomes in r/r B-Cell Acute Lymphoblastic Leukemia
December 3rd 2024CAR T-cell therapy obecabtagene autoleucel produced high response rates, durable outcomes, and low toxicity in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia, especially benefiting those with low-to-intermediate bone marrow burden.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Opdivo plus Yervoy Significantly Outperforms Chemotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
December 2nd 2024Phase III CheckMate 8HW trial results demonstrated that the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) significantly improves progression-free survival and has a better safety profile compared to chemotherapy in the first-line treatment of MSI-H or dMMR metastatic colorectal cancer.